Annual Report 2024 released
April 28, 2025
ACT 2024: Stay Ahead With Scantox’s Expanded Toxicology Services
November 4, 2024
Scantox Showcases Cell and Gene Therapy Capabilities at ESGCT 2024
September 29, 2024
Discover Scantox’s Innovative Preclinical Model Systems at Neuroscience 2024
September 18, 2024
Scantox Group acquires Gentronix, a world leader in genetic toxicology
September 9, 2024
Maximize Partnership Opportunities at Eurotox and NLS Days
August 22, 2024
Neuro4D: A Focused Meeting of Neuroscience Experts
May 14, 2024
Annual Report 2023 released
April 24, 2024
Scantox acquires QPS Austria’s Neuropharmacology Division
November 30, 2023
Exclusive genOway distributors in the Nordics
June 14, 2023
Scantox Certified as 2023 Great Place to Work
April 26, 2023
